NABULSI AZMI (Chief Operating Officer) received a stock award from PHATHOM PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/3/2023ACC: 0001209191-23-054352
Officer· Chief Operating Officer
Since Oct 2019
+32.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
32.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+32.50K
Price / share
—
Trade value
—
% of position
15.5%
11/1/2023
209.57K→242.07K
Total
Net shares
+32.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2023 | A · Award | +32.50K | — | — | 15.5% | 209.57K | 242.07K |
| Total | +32.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned3.58K
Common Stock
IndirectShares owned785.70K
Total
789.28K indirect789.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.58K | Indirect |
| Common Stock | 785.70K | Indirect |
| Total | 789.28K | 789.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported